Researchers identify biomarkers for pancreatic cancer

06/15/2008 | Washington Post (tiered subscription model), The

Researchers have pinpointed five proteins associated with early-stage pancreatic cancer in bioengineered mice that were also found to be linked to a presymptomatic stage of the disease in humans. A commercial screening test that uses the five-biomarker panel could prove beneficial in detecting early-stage pancreatic cancer when used in tandem with a commercially available test that determines the levels of the biomarker CA19.9.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC